FDA opens docket on VOQUEZNA exclusivity dispute; second ANDA filer Saba Ilac seeks consolidation with BDR case

Phathom Pharmaceuticals provided a litigation update, saying the FDA has opened a docket on the VOQUEZNA exclusivity dispute and that second ANDA filer Saba Ilac plans to seek consolidation with the BDR case.

Detected & updated continuously · Source: Nebula